Vedder Price

Vedder Thinking | Events Shareholder Thomas Kowalski to Present at C5’s Pharma and Biotech Patent Litigation Conference in Amsterdam

Seminar

When

March 14, 2016 - March 15, 2016

Thomas J. Kowalski, a Shareholder in the New York office and a member of the firm’s Intellectual Property group, will present “The 101 Issue: Patent Eligibility in the United States–Should Europe Fear the US System?” at C5’s 8th Pharma & Biotech Patent Litigation Conference on March 15. The conference will provide an invaluable focus for analysis of all the fundamental changes affecting pharma and biotech patents across Europe and the United States and will consider the impact of judicial decisions in the national courts on litigation strategies.

Mr. Kowalski will review recent U.S. case law, current guidelines for patent eligibility, where challenges lie, the current mood in the United States, the sort of claims allowed in the United States, the attitude towards biotech ventures going forward and finally, best practices for patent drafting.

Additional information on the conference can be found here.




Professionals



Thomas J. Kowalski

Shareholder